AVTE
Closed
Aerovate Therapeutics Inc
2.68
0.00 (0.00%)
Last Update: 28 Apr 2025 23:28:00
Yesterday: 2.68
Day's Range: 2.6296 - 2.77
Send
sign up or login to leave a comment!
When Written:
20.255
Aerovate Therapeutics Inc is a biopharmaceutical company that focuses on developing treatments for serious cardiopulmonary diseases. The company was founded in 2018 and is based in St. Paul, Minnesota. Aerovate Therapeutics Inc's lead product candidate is AV-101, a treatment for pulmonary arterial hypertension (PAH). The company is also developing other product candidates for PAH and other cardiopulmonary diseases. Aerovate Therapeutics Inc is backed by a group of venture capital firms and has partnerships with academic institutions and other biopharmaceutical companies.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








